Suppression of paroxysmal atrial tachyarrhythmias — results of the SOPAT trial

[1]  G. Breithardt,et al.  Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial. , 2004, European heart journal.

[2]  A. Simone,et al.  Verapamil plus antiarrhythmic drugs reduce atrial fibrillation recurrences after an electrical cardioversion (VEPARAF study) , 2004 .

[3]  M. di Mauro,et al.  VErapamil plus antiarrhythmic drugs reduce atrial fibrillation recurrences after an electrical cardioversion (VEPARAF Study). , 2003, European heart journal.

[4]  H. Crijns,et al.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. , 2002, The New England journal of medicine.

[5]  H. Crijns,et al.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation , 2002 .

[6]  S. Connolly,et al.  Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation. , 2002, American heart journal.

[7]  B. Lüderitz,et al.  Die medikamentöse Anfallsprophylaxe bei symptomatischem paroxysmalem Vorhofflimmern/-flattern Ziele und Design der SOPAT-Studie , 1999, Zeitschrift für Kardiologie.

[8]  M. Allessie,et al.  Verapamil reduces tachycardia-induced electrical remodeling of the atria. , 1997, Circulation.

[9]  G. Innes,et al.  Effectiveness of verapamil-quinidine versus digoxin-quinidine in the emergency department treatment of paroxysmal atrial fibrillation. , 1997, Annals of emergency medicine.

[10]  R. Kronmal,et al.  Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. , 1992, Journal of the American College of Cardiology.

[11]  S. Hohnloser,et al.  Effects of amiodarone versus quinidine and verapamil in patients with chronic atrial fibrillation: results of a comparative study and a 2-year follow-up. , 1992, Journal of the American College of Cardiology.

[12]  J. Goin,et al.  Quinidine‐Related Mortality in the Short‐to‐Medium‐Term Treatment of Ventricular Arrhythmias: A Meta‐Analysis , 1991, Circulation.

[13]  E. Antman,et al.  Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. , 1990, Circulation.

[14]  B. Brisse,et al.  [Combined treatment of auricular fibrillation and other tachycardiac arrhythmias using quinidine and verapamil]. , 1972, Die Medizinische Welt.